SC Liver Research Consortium
SC Liver Research Consortium (SCLRC) is an organization of physicians specializing in hepatology and gastroenterology clinical research. Our mission is to team research sponsors and our network of over 85 research sites together to provide faster, higher-quality research results. The network enrolls high volume Phase I-IV clinical hepatology, gastroenterology, and oncology trials faster than the traditional one-site-at-a-time start-up model. We provide access to scientific expertise in study design, efficient site selection, streamlined contract and budget negotiations, and management assistance throughout the clinical trial. SCLRC also offers national CME training series focusing on liver diseases.
Industries
Nr. of Employees
small (1-50)
SC Liver Research Consortium
Services
Assemble panels of clinical experts to advise on study design, protocol development and program strategy.
Provide strategic design input and assist with preparation and presentation of proposals to regulatory authorities.
Provide standardized master agreement templates and network-wide research guidelines aligned with ICH and FDA regulations; execute study-specific riders.
Develop and deliver accredited CME programs in live, hybrid and web-based formats focused on liver disease topics.
Advise sponsors on selection of CRO partners and coordinate collaboration between CROs and consortium sites.
Provide access to sites capable of Phase I–IV trials and 24-hour in-house pharmacokinetic testing and sample handling when required.
Assemble panels of clinical experts to advise on study design, protocol development and program strategy.
Provide strategic design input and assist with preparation and presentation of proposals to regulatory authorities.
Provide standardized master agreement templates and network-wide research guidelines aligned with ICH and FDA regulations; execute study-specific riders.
Develop and deliver accredited CME programs in live, hybrid and web-based formats focused on liver disease topics.
Advise sponsors on selection of CRO partners and coordinate collaboration between CROs and consortium sites.
Provide access to sites capable of Phase I–IV trials and 24-hour in-house pharmacokinetic testing and sample handling when required.
Expertise Areas
- Clinical trial management
- Site network development and management
- Subject recruitment and enrollment optimization
- Protocol development and regulatory advisory
Key Technologies
- Pharmacokinetic (PK) assays
- Enzyme-linked immunosorbent assays (ELISA) for biomarker measurement
- Viral load nucleic acid testing (PCR-based assays)
- Cell-free DNA (cfDNA) methylation assays
News & Updates
List of ongoing clinical trials including studies on NASH, liver fibrosis, hepatitis, and liver cancer.
List of completed or closed clinical trials on various liver diseases.
List of ongoing clinical trials including studies on NASH, liver fibrosis, hepatitis, and liver cancer.
List of completed or closed clinical trials on various liver diseases.